FASN and ovarian carcinoma: Ovarian cancer cells utilize lipid metabolism in the ascites or omental microenvironment during metastatic progression through AMPK/ACC/FASN-mediated lipogenesis and AMPK/TAK1/NF-κB signaling pathways.